Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials.

IF 2.3 4区医学 Q3 PHARMACOLOGY & PHARMACY

Annals of Pharmacotherapy Pub Date : 2024-11-01 Epub Date: 2023-11-28 DOI:10.1177/10600280231211304

Marina Sánchez-Rico, Katayoun Rezaei, Eric J Lenze, Frédéric Limosin, Nicolas Hoertel

引用次数: 0

查看原文本刊更多论文

氟伏沙明对门诊COVID-19患者的疗效:理解最近两项相同临床试验的meta分析的相互矛盾的结论

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Pharmacotherapy 医学-药学

CiteScore

5.70

自引率

0.00%

发文量

166

审稿时长

3-8 weeks

期刊介绍： Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days